Management of choroidal/ciliary body metastasis in the era of targeted cancer therapy

Patients with choroidal/ciliary body metastasis treated with either EBR or systemic therapy can have good visual outcomes. More work needs to be conducted to determine the optimal first-line treatment of ocular metastasis for specific tumor subtypes.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2024-12-20
DOI
https://doi.org/10.3389/fonc.2024.1516783
Citations
2
Primary Topic
Ocular Oncology and Treatments
Type
article
Field-Weighted Citation Impact
1.08
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Management of choroidal/ciliary body metastasis in the era of targeted cancer therapy

Farzad Jamshidi, H. Culver Boldt, Carryn M. Anderson, Elaine M. Binkley et al.
2 citations
Frontiers in Oncology
Ocular Oncology and Treatments
1.08
article

Management of choroidal/ciliary body metastasis in the era of targeted cancer therapy

Farzad Jamshidi, H. Culver Boldt, Carryn M. Anderson, Elaine M. Binkley, Moses O. Evbuomwan, Uwajachukwumma A. Uzomah, Rupak Bhuyan
article en
2 citations

Abstract

Patients with choroidal/ciliary body metastasis treated with either EBR or systemic therapy can have good visual outcomes. More work needs to be conducted to determine the optimal first-line treatment of ocular metastasis for specific tumor subtypes.

Frontiers in OncologyVol. 14
University of Iowa (US)
Good health and well-being
Openalex Percentile: Top 20%
Ocular Oncology and Treatments
1.08
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.